Spiro Rombotis | President and CEO |
Paul McBarron | EVP, Finance and COO and Secretary |
Judy Chiao | VP, Clinical Development and Regulatory Affairs |
Alexander Fudukidis | IR, Russo Partners LLC |
Wangzhi Li | Ladenburg Thalmann & Co. |
Good afternoon, and welcome to the Cyclacel Pharmaceuticals First Quarter 2019 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. After today’s call, members of financial community will have an opportunity to ask questions. [Operator Instructions]. The company will also be accepting a limited number of questions submitted via e-mail to the address, ir@cyclacel.com.